158 results
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
3 Dec 19
Departure of Directors or Certain Officers
6:55am
the payments the Company is obligated to make pursuant to this Plan.
7. Tax Withholdings. The Company shall withhold all taxes required by state, federal … enforcing each and every other provision of the Plan.
19. Section 409A of the Code.Although the Company does not guarantee the tax treatment of any
8-K
EX-2.1
KPRX
Kiora Pharmaceuticals Inc
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
the benefit following the Closing, (b) deferred Tax assets, and (c) receivables from any of the Company's Affiliates, directors, employees, officers … , employees, officers or stockholders and any of their respective Affiliates, deferred Tax liabilities, Transaction Expenses and the current portion of any
DRS/A
EX-10.2
zkhhu
8 Jul 14
Draft registration statement (amended)
12:00am
8-K
EX-2.1
wq0 wnn7sk
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-99.1
k37ns8xchnsmymybuty
25 Mar 24
Results of Operations and Financial Condition
7:03am
8-K/A
EX-99.2
3jzf8q6so6kkhr
5 Mar 21
Financial Statements and Exhibits
4:15pm
DRS/A
mvw tm3z51m
8 Jul 14
Draft registration statement (amended)
12:00am
424B4
e94oqdit 99skl
13 Feb 15
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
tqf3o7 oe
9 Nov 23
Results of Operations and Financial Condition
7:01am
PRE 14A
glfob6
17 May 18
Preliminary proxy
5:21pm